How Much Do GLP-1 Medications Cost Without Insurance?
Brand list prices, cash-pay compounded options, and what actually drives the cost difference.
Cost is one of the biggest barriers to GLP-1 therapy, especially since many insurance plans exclude weight-loss medications. Understanding what you are actually paying for — and why prices differ so much — helps you plan.
Here is a clear breakdown of GLP-1 costs without insurance and what drives the difference between brand-name and compounded options.
Brand-name list prices
Brand-name GLP-1s are typically the most expensive option before insurance. Wegovy (semaglutide) commonly lists around $1,300+ per month and Zepbound (tirzepatide) around $1,000+ per month at list price. Manufacturer self-pay programs exist for some products, but the cost is still significant for many people, and coverage for weight-loss indications is inconsistent.
Provider-prescribed compounded options
Compounded semaglutide and tirzepatide are prepared by state-licensed 503A pharmacies and are typically offered cash-pay at a lower price than brand list prices. At ZENKAI, provider-prescribed compounded semaglutide starts at $199/month and compounded tirzepatide at $299/month, with provider review and shipping included. Prices and availability change.
| Brand-name | Compounded (ZENKAI) | |
|---|---|---|
| Semaglutide | Wegovy ~$1,300+/mo list | From $199/mo cash-pay |
| Tirzepatide | Zepbound ~$1,000+/mo list | From $299/mo cash-pay |
| FDA status | FDA-approved | Not FDA-approved |
| Insurance | Sometimes covered, often excluded | No insurance required |
About compounded medications
Compounded semaglutide and tirzepatide are prepared by state-licensed 503A compounding pharmacies for an individual patient after a provider consultation. They are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are only appropriate when a licensed provider determines they are clinically suitable for you.
What drives the difference
Brand-name medications carry the cost of FDA approval, large-scale manufacturing, and marketing. Compounded medications are prepared by pharmacies for individual patients and are not FDA-approved, which is part of why the cash price is lower. Price should never be the only factor — legitimacy, pharmacy licensing, and provider oversight matter most.
What to look for in a cash-pay program
Transparent pricing with no surprise fees, a US-licensed provider who reviews your history, medications from a state-licensed pharmacy, and LegitScript certification. ZENKAI is LegitScript certified and lists its pricing upfront.
See if a GLP-1 is right for you
Complete a short online intake. A US-licensed provider reviews your history and goals — no insurance required.
Start your free assessmentFrequently asked questions
Why is compounded GLP-1 less expensive than the brand?
Compounded medications are prepared by compounding pharmacies for individual patients rather than sold as branded, FDA-approved products, which generally lowers the cash price. Legitimacy and provider oversight should still come first.
Does insurance cover GLP-1 for weight loss?
Coverage is inconsistent. Many plans cover GLP-1s for diabetes but exclude them for weight management. Cash-pay compounded programs exist specifically because so many people are not covered.
What does ZENKAI charge?
Provider-prescribed compounded semaglutide starts at $199/month and compounded tirzepatide at $299/month, cash-pay, with provider review and shipping included. Confirm current pricing during your consultation.
This article is for general education and is not medical advice. It does not establish a provider-patient relationship. Compounded semaglutide and tirzepatide are prepared by state-licensed 503A pharmacies, are not FDA-approved, and are only appropriate when a licensed provider determines they are suitable for you. Prescribing and treatment decisions are made independently by licensed providers. You must be 21 or older to use ZENKAI. Results vary.